nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Etoposide—sarcoma	0.344	0.542	CbGbCtD
Trisalicylate-choline—PTGS1—Etoposide—sarcoma	0.291	0.458	CbGbCtD
Trisalicylate-choline—PTGS2—periosteum—sarcoma	0.0158	0.125	CbGeAlD
Trisalicylate-choline—PTGS2—leg—sarcoma	0.0126	0.0995	CbGeAlD
Trisalicylate-choline—PTGS2—hindlimb—sarcoma	0.0113	0.0889	CbGeAlD
Trisalicylate-choline—PTGS2—cartilage tissue—sarcoma	0.0111	0.0875	CbGeAlD
Trisalicylate-choline—PTGS2—appendage—sarcoma	0.00966	0.0762	CbGeAlD
Trisalicylate-choline—Epigastric pain—Mitoxantrone—sarcoma	0.00703	0.0295	CcSEcCtD
Trisalicylate-choline—PTGS1—endothelium—sarcoma	0.0061	0.0481	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—sarcoma	0.00583	0.046	CbGeAlD
Trisalicylate-choline—Hypocalcaemia—Dactinomycin—sarcoma	0.00427	0.0179	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Thiotepa—sarcoma	0.00413	0.0173	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Thiotepa—sarcoma	0.00376	0.0158	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Mitoxantrone—sarcoma	0.00371	0.0156	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Thiotepa—sarcoma	0.00359	0.0151	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Dactinomycin—sarcoma	0.00357	0.015	CcSEcCtD
Trisalicylate-choline—PTGS2—myometrium—sarcoma	0.00333	0.0263	CbGeAlD
Trisalicylate-choline—PTGS2—embryo—sarcoma	0.00321	0.0253	CbGeAlD
Trisalicylate-choline—Deafness—Thiotepa—sarcoma	0.00319	0.0134	CcSEcCtD
Trisalicylate-choline—PTGS1—seminal vesicle—sarcoma	0.00315	0.0249	CbGeAlD
Trisalicylate-choline—Ecchymosis—Mitoxantrone—sarcoma	0.00307	0.0129	CcSEcCtD
Trisalicylate-choline—PTGS2—seminal vesicle—sarcoma	0.00301	0.0238	CbGeAlD
Trisalicylate-choline—PTGS1—hematopoietic system—sarcoma	0.00299	0.0236	CbGeAlD
Trisalicylate-choline—Lethargy—Dactinomycin—sarcoma	0.00289	0.0121	CcSEcCtD
Trisalicylate-choline—PTGS1—connective tissue—sarcoma	0.00288	0.0228	CbGeAlD
Trisalicylate-choline—PTGS2—hematopoietic system—sarcoma	0.00286	0.0226	CbGeAlD
Trisalicylate-choline—Deafness—Vincristine—sarcoma	0.00283	0.0119	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Epirubicin—sarcoma	0.00283	0.0119	CcSEcCtD
Trisalicylate-choline—Hypothermia—Epirubicin—sarcoma	0.00283	0.0119	CcSEcCtD
Trisalicylate-choline—PTGS2—connective tissue—sarcoma	0.00276	0.0218	CbGeAlD
Trisalicylate-choline—Gastric ulcer—Epirubicin—sarcoma	0.00273	0.0114	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Etoposide—sarcoma	0.0027	0.0113	CcSEcCtD
Trisalicylate-choline—PTGS1—smooth muscle tissue—sarcoma	0.00264	0.0208	CbGeAlD
Trisalicylate-choline—Hypothermia—Doxorubicin—sarcoma	0.00261	0.011	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Doxorubicin—sarcoma	0.00261	0.011	CcSEcCtD
Trisalicylate-choline—PTGS1—skin of body—sarcoma	0.0026	0.0206	CbGeAlD
Trisalicylate-choline—Oesophagitis—Etoposide—sarcoma	0.00258	0.0108	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Doxorubicin—sarcoma	0.00252	0.0106	CcSEcCtD
Trisalicylate-choline—PTGS2—smooth muscle tissue—sarcoma	0.00252	0.0199	CbGeAlD
Trisalicylate-choline—PTGS2—skin of body—sarcoma	0.00249	0.0196	CbGeAlD
Trisalicylate-choline—Burning sensation—Epirubicin—sarcoma	0.00228	0.00956	CcSEcCtD
Trisalicylate-choline—PTGS1—cardiac atrium—sarcoma	0.00227	0.018	CbGeAlD
Trisalicylate-choline—PTGS1—uterus—sarcoma	0.00226	0.0179	CbGeAlD
Trisalicylate-choline—Abdominal pain upper—Mitoxantrone—sarcoma	0.00225	0.00945	CcSEcCtD
Trisalicylate-choline—Weight increased—Thiotepa—sarcoma	0.00225	0.00942	CcSEcCtD
Trisalicylate-choline—PTGS2—uterus—sarcoma	0.00216	0.0171	CbGeAlD
Trisalicylate-choline—Burning sensation—Doxorubicin—sarcoma	0.00211	0.00885	CcSEcCtD
Trisalicylate-choline—Epistaxis—Thiotepa—sarcoma	0.00208	0.00871	CcSEcCtD
Trisalicylate-choline—PTGS2—lymphoid tissue—sarcoma	0.00202	0.0159	CbGeAlD
Trisalicylate-choline—PTGS1—tendon—sarcoma	0.00198	0.0156	CbGeAlD
Trisalicylate-choline—Hallucination—Thiotepa—sarcoma	0.00197	0.00825	CcSEcCtD
Trisalicylate-choline—Hepatitis—Dactinomycin—sarcoma	0.00196	0.00822	CcSEcCtD
Trisalicylate-choline—Stinging—Epirubicin—sarcoma	0.00196	0.0082	CcSEcCtD
Trisalicylate-choline—Weight increased—Mitoxantrone—sarcoma	0.00194	0.00814	CcSEcCtD
Trisalicylate-choline—Drowsiness—Mitoxantrone—sarcoma	0.0019	0.00797	CcSEcCtD
Trisalicylate-choline—PTGS2—tendon—sarcoma	0.00189	0.015	CbGeAlD
Trisalicylate-choline—Sweating—Vincristine—sarcoma	0.00187	0.00785	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Dactinomycin—sarcoma	0.00185	0.00778	CcSEcCtD
Trisalicylate-choline—Tinnitus—Thiotepa—sarcoma	0.00184	0.00773	CcSEcCtD
Trisalicylate-choline—PTGS2—bone marrow—sarcoma	0.00183	0.0145	CbGeAlD
Trisalicylate-choline—Sweating—Mitoxantrone—sarcoma	0.00182	0.00764	CcSEcCtD
Trisalicylate-choline—Flushing—Dactinomycin—sarcoma	0.00182	0.00763	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—sarcoma	0.00181	0.00759	CcSEcCtD
Trisalicylate-choline—Hallucination—Vincristine—sarcoma	0.00174	0.00731	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Epirubicin—sarcoma	0.00173	0.00726	CcSEcCtD
Trisalicylate-choline—Erythema—Thiotepa—sarcoma	0.00172	0.00721	CcSEcCtD
Trisalicylate-choline—Erythema—Dactinomycin—sarcoma	0.00171	0.00716	CcSEcCtD
Trisalicylate-choline—Hepatitis—Mitoxantrone—sarcoma	0.00171	0.00716	CcSEcCtD
Trisalicylate-choline—PTGS1—testis—sarcoma	0.00164	0.013	CbGeAlD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—sarcoma	0.0016	0.00672	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Epirubicin—sarcoma	0.00157	0.00661	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Epirubicin—sarcoma	0.00151	0.00634	CcSEcCtD
Trisalicylate-choline—Erythema—Mitoxantrone—sarcoma	0.00149	0.00623	CcSEcCtD
Trisalicylate-choline—PTGS2—liver—sarcoma	0.00148	0.0117	CbGeAlD
Trisalicylate-choline—Injection site reaction—Doxorubicin—sarcoma	0.00146	0.00611	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Mitoxantrone—sarcoma	0.00145	0.0061	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—sarcoma	0.00145	0.00607	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—sarcoma	0.00143	0.00601	CcSEcCtD
Trisalicylate-choline—Confusional state—Thiotepa—sarcoma	0.00142	0.00594	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—sarcoma	0.0014	0.00587	CcSEcCtD
Trisalicylate-choline—Oedema—Dactinomycin—sarcoma	0.00139	0.00584	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Etoposide—sarcoma	0.00134	0.00563	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—sarcoma	0.00134	0.00562	CcSEcCtD
Trisalicylate-choline—Anorexia—Thiotepa—sarcoma	0.00134	0.00561	CcSEcCtD
Trisalicylate-choline—Anorexia—Dactinomycin—sarcoma	0.00133	0.00557	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—sarcoma	0.00133	0.00556	CcSEcCtD
Trisalicylate-choline—Flushing—Etoposide—sarcoma	0.00132	0.00552	CcSEcCtD
Trisalicylate-choline—Somnolence—Thiotepa—sarcoma	0.00125	0.00523	CcSEcCtD
Trisalicylate-choline—Oedema—Vincristine—sarcoma	0.00124	0.00522	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Thiotepa—sarcoma	0.00124	0.00518	CcSEcCtD
Trisalicylate-choline—Confusional state—Mitoxantrone—sarcoma	0.00122	0.00513	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Thiotepa—sarcoma	0.00122	0.00512	CcSEcCtD
Trisalicylate-choline—Oedema—Mitoxantrone—sarcoma	0.00121	0.00508	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dactinomycin—sarcoma	0.00121	0.00508	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Etoposide—sarcoma	0.00121	0.00507	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Vincristine—sarcoma	0.0012	0.00505	CcSEcCtD
Trisalicylate-choline—Pain—Thiotepa—sarcoma	0.0012	0.00503	CcSEcCtD
Trisalicylate-choline—Constipation—Thiotepa—sarcoma	0.0012	0.00503	CcSEcCtD
Trisalicylate-choline—Shock—Mitoxantrone—sarcoma	0.00119	0.005	CcSEcCtD
Trisalicylate-choline—Pain—Dactinomycin—sarcoma	0.00119	0.005	CcSEcCtD
Trisalicylate-choline—PTGS1—lymph node—sarcoma	0.00119	0.00939	CbGeAlD
Trisalicylate-choline—Anorexia—Vincristine—sarcoma	0.00119	0.00498	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—sarcoma	0.00117	0.00492	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Mitoxantrone—sarcoma	0.00117	0.00491	CcSEcCtD
Trisalicylate-choline—Hypotension—Vincristine—sarcoma	0.00116	0.00488	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Thiotepa—sarcoma	0.00116	0.00485	CcSEcCtD
Trisalicylate-choline—Anorexia—Mitoxantrone—sarcoma	0.00116	0.00485	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dactinomycin—sarcoma	0.00115	0.00482	CcSEcCtD
Trisalicylate-choline—PTGS2—lymph node—sarcoma	0.00114	0.00898	CbGeAlD
Trisalicylate-choline—Hypotension—Mitoxantrone—sarcoma	0.00113	0.00475	CcSEcCtD
Trisalicylate-choline—Urticaria—Thiotepa—sarcoma	0.00112	0.00468	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—sarcoma	0.00109	0.00455	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vincristine—sarcoma	0.00108	0.00454	CcSEcCtD
Trisalicylate-choline—Somnolence—Mitoxantrone—sarcoma	0.00108	0.00452	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mitoxantrone—sarcoma	0.00107	0.00448	CcSEcCtD
Trisalicylate-choline—Constipation—Vincristine—sarcoma	0.00106	0.00446	CcSEcCtD
Trisalicylate-choline—Pain—Vincristine—sarcoma	0.00106	0.00446	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mitoxantrone—sarcoma	0.00105	0.00442	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—sarcoma	0.00105	0.00441	CcSEcCtD
Trisalicylate-choline—Pain—Mitoxantrone—sarcoma	0.00104	0.00435	CcSEcCtD
Trisalicylate-choline—Constipation—Mitoxantrone—sarcoma	0.00104	0.00435	CcSEcCtD
Trisalicylate-choline—Confusional state—Etoposide—sarcoma	0.00102	0.00426	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Mitoxantrone—sarcoma	0.000999	0.00419	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—sarcoma	0.000994	0.00417	CcSEcCtD
Trisalicylate-choline—Pruritus—Thiotepa—sarcoma	0.000993	0.00417	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Etoposide—sarcoma	0.000975	0.00409	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—sarcoma	0.000972	0.00408	CcSEcCtD
Trisalicylate-choline—Urticaria—Mitoxantrone—sarcoma	0.000963	0.00404	CcSEcCtD
Trisalicylate-choline—Anorexia—Etoposide—sarcoma	0.000961	0.00403	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Thiotepa—sarcoma	0.00096	0.00403	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dactinomycin—sarcoma	0.000953	0.004	CcSEcCtD
Trisalicylate-choline—Hypotension—Etoposide—sarcoma	0.000942	0.00395	CcSEcCtD
Trisalicylate-choline—Dizziness—Thiotepa—sarcoma	0.000928	0.00389	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—sarcoma	0.00092	0.00386	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—sarcoma	0.000904	0.00379	CcSEcCtD
Trisalicylate-choline—Somnolence—Etoposide—sarcoma	0.000896	0.00376	CcSEcCtD
Trisalicylate-choline—Vomiting—Thiotepa—sarcoma	0.000892	0.00374	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—sarcoma	0.000886	0.00372	CcSEcCtD
Trisalicylate-choline—Vomiting—Dactinomycin—sarcoma	0.000886	0.00372	CcSEcCtD
Trisalicylate-choline—Rash—Thiotepa—sarcoma	0.000885	0.00371	CcSEcCtD
Trisalicylate-choline—Dermatitis—Thiotepa—sarcoma	0.000884	0.00371	CcSEcCtD
Trisalicylate-choline—Headache—Thiotepa—sarcoma	0.000879	0.00369	CcSEcCtD
Trisalicylate-choline—Rash—Dactinomycin—sarcoma	0.000878	0.00368	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Etoposide—sarcoma	0.000876	0.00368	CcSEcCtD
Trisalicylate-choline—Pain—Etoposide—sarcoma	0.000862	0.00362	CcSEcCtD
Trisalicylate-choline—Constipation—Etoposide—sarcoma	0.000862	0.00362	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vincristine—sarcoma	0.000852	0.00357	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—sarcoma	0.00085	0.00356	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—sarcoma	0.000837	0.00351	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—sarcoma	0.000836	0.00351	CcSEcCtD
Trisalicylate-choline—Nausea—Thiotepa—sarcoma	0.000834	0.0035	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etoposide—sarcoma	0.000831	0.00348	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mitoxantrone—sarcoma	0.000829	0.00348	CcSEcCtD
Trisalicylate-choline—Nausea—Dactinomycin—sarcoma	0.000827	0.00347	CcSEcCtD
Trisalicylate-choline—Dizziness—Vincristine—sarcoma	0.000823	0.00345	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—sarcoma	0.00082	0.00344	CcSEcCtD
Trisalicylate-choline—Urticaria—Etoposide—sarcoma	0.000801	0.00336	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—sarcoma	0.000796	0.00334	CcSEcCtD
Trisalicylate-choline—Vomiting—Vincristine—sarcoma	0.000791	0.00332	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—sarcoma	0.000786	0.0033	CcSEcCtD
Trisalicylate-choline—Rash—Vincristine—sarcoma	0.000785	0.00329	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vincristine—sarcoma	0.000784	0.00329	CcSEcCtD
Trisalicylate-choline—Headache—Vincristine—sarcoma	0.00078	0.00327	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—sarcoma	0.000773	0.00324	CcSEcCtD
Trisalicylate-choline—Vomiting—Mitoxantrone—sarcoma	0.000771	0.00323	CcSEcCtD
Trisalicylate-choline—Rash—Mitoxantrone—sarcoma	0.000764	0.00321	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mitoxantrone—sarcoma	0.000764	0.0032	CcSEcCtD
Trisalicylate-choline—Headache—Mitoxantrone—sarcoma	0.000759	0.00319	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—sarcoma	0.000752	0.00315	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—sarcoma	0.000742	0.00311	CcSEcCtD
Trisalicylate-choline—Nausea—Vincristine—sarcoma	0.000739	0.0031	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—sarcoma	0.000738	0.0031	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—sarcoma	0.000736	0.00309	CcSEcCtD
Trisalicylate-choline—Nausea—Mitoxantrone—sarcoma	0.00072	0.00302	CcSEcCtD
Trisalicylate-choline—Pruritus—Etoposide—sarcoma	0.000713	0.00299	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—sarcoma	0.000696	0.00292	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—sarcoma	0.000693	0.0029	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etoposide—sarcoma	0.00069	0.00289	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—sarcoma	0.000686	0.00288	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—sarcoma	0.000683	0.00287	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—sarcoma	0.000678	0.00284	CcSEcCtD
Trisalicylate-choline—Dizziness—Etoposide—sarcoma	0.000667	0.0028	CcSEcCtD
Trisalicylate-choline—Vomiting—Etoposide—sarcoma	0.000641	0.00269	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—sarcoma	0.000641	0.00269	CcSEcCtD
Trisalicylate-choline—Rash—Etoposide—sarcoma	0.000636	0.00267	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etoposide—sarcoma	0.000635	0.00266	CcSEcCtD
Trisalicylate-choline—Headache—Etoposide—sarcoma	0.000632	0.00265	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—sarcoma	0.000627	0.00263	CcSEcCtD
Trisalicylate-choline—Nausea—Etoposide—sarcoma	0.000599	0.00251	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—sarcoma	0.00057	0.00239	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—sarcoma	0.000565	0.00237	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—sarcoma	0.000556	0.00233	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—sarcoma	0.000546	0.00229	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—sarcoma	0.000539	0.00226	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—sarcoma	0.000528	0.00222	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—sarcoma	0.000527	0.00221	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—sarcoma	0.000523	0.00219	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—sarcoma	0.000514	0.00216	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—sarcoma	0.000506	0.00212	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—sarcoma	0.000502	0.00211	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—sarcoma	0.000498	0.00209	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—sarcoma	0.000498	0.00209	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—sarcoma	0.000491	0.00206	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—sarcoma	0.000489	0.00205	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—sarcoma	0.000483	0.00203	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—sarcoma	0.000483	0.00203	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—sarcoma	0.000466	0.00195	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—sarcoma	0.000465	0.00195	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—sarcoma	0.00046	0.00193	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—sarcoma	0.000455	0.00191	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—sarcoma	0.000449	0.00188	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—sarcoma	0.000447	0.00188	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—sarcoma	0.000447	0.00188	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—sarcoma	0.000431	0.00181	CcSEcCtD
Trisalicylate-choline—Urticaria—Doxorubicin—sarcoma	0.000415	0.00174	CcSEcCtD
Trisalicylate-choline—Pruritus—Epirubicin—sarcoma	0.0004	0.00168	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—sarcoma	0.000387	0.00162	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—sarcoma	0.000374	0.00157	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—sarcoma	0.00037	0.00155	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—sarcoma	0.000359	0.00151	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—sarcoma	0.000358	0.0015	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—sarcoma	0.000356	0.00149	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—sarcoma	0.000356	0.00149	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—sarcoma	0.000354	0.00149	CcSEcCtD
Trisalicylate-choline—Dizziness—Doxorubicin—sarcoma	0.000346	0.00145	CcSEcCtD
Trisalicylate-choline—Nausea—Epirubicin—sarcoma	0.000336	0.00141	CcSEcCtD
Trisalicylate-choline—Vomiting—Doxorubicin—sarcoma	0.000332	0.00139	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—sarcoma	0.00033	0.00138	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—sarcoma	0.000329	0.00138	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—sarcoma	0.000328	0.00137	CcSEcCtD
Trisalicylate-choline—Nausea—Doxorubicin—sarcoma	0.000311	0.0013	CcSEcCtD
